ARCHIVES

UHC Expands Risk Models To Include 25 Cancer Variables

This article is from The Cancer Letter archive.

Vol. 35 No. 2 | February 24, 2012

Download PDF Visit The Full Archive

Related Articles

Report Urges Better Working Conditions For Postdocs.

October 6, 2000

J&J To Eliminate Its Ortho Biotech Unit As FDA Considers Further Limits On ESAs.

May 2, 2008

In Brief: Arkansas, Iowa Appoint Center Directors; Broder Moves To Gene Sequencing Venture

August 14, 1998

Cancer Center In Russia Seeks Cancer Drugs, Other Supplies, From US

July 30, 1993

Letters: Broder Response To Waxman Called Political Back-Pedaling

February 11, 1994

Amgen Agrees to Settle Aranesp Marketing Lawsuit, Reserves $780 Million For Settlement

October 28, 2011